Skip to main content
Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.460
+0.060 (4.29%)
At close: Mar 9, 2026, 4:00 PM EDT
1.440
-0.020 (-1.36%)
After-hours: Mar 9, 2026, 6:35 PM EDT

Lucid Diagnostics Revenue

Lucid Diagnostics had revenue of $1.21M in the quarter ending September 30, 2025, with 3.33% growth. This brings the company's revenue in the last twelve months to $4.40M, up 5.01% year-over-year. In the year 2024, Lucid Diagnostics had annual revenue of $4.35M with 79.00% growth.

Revenue (ttm)
$4.40M
Revenue Growth
+5.01%
P/S Ratio
45.70
Revenue / Employee
$61,097
Employees
72
Market Cap
201.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.35M1.92M79.00%
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
InfuSystem Holdings 143.44M
Owlet 105.70M
Sight Sciences 77.36M
Electromed 68.86M
CVRx, Inc. 56.65M
SANUWAVE Health 41.28M
Rapid Micro Biosystems 30.52M
Revenue Rankings

LUCD News

More News